Preferred partnership: Difference between revisions
Content deleted Content added
added a few references. Not the strongest, but a start. |
|||
| Line 5: | Line 5: | ||
* Minimum sales volume and/or value |
* Minimum sales volume and/or value |
||
Being a preferred partner provides pre-determined [[discounts and allowances|discount]]s, advantages and privileges from the vendor to the partner.<ref>{{Cite book|last=Gassmann|first=Oliver|url=https://books.google.com |
Being a preferred partner provides pre-determined [[discounts and allowances|discount]]s, advantages and privileges from the vendor to the partner.<ref>{{Cite book|last=Gassmann|first=Oliver|url=https://books.google.com/books?id=iry1nJHAc_sC&pg=PA130 |title=Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry|last2=Reepmeyer|first2=Gerrit|last3=Zedtwitz|first3=Maximilian von|date=2008-02-19|publisher=Springer Science & Business Media|isbn=978-3-540-77636-9|language=en}}</ref><ref>{{Cite book|url=https://books.google.com/books?id=5kc-AQAAIAAJ&q=preferred+partner+program&dq=preferred+partner+program |title=Investment Management Regulation: ALI-ABA Course of Study Materials|date=2006|publisher=American Law Institute-American Bar Association Committee on Continuing Professional Education|language=en}}</ref> |
||
[[Category:Business terms]] |
[[Category:Business terms]] |
||
Revision as of 17:46, 30 June 2020
 | This article needs additional citations for verification. (April 2020) |
A preferred partner agreement normally refers to an agreement between a vendor (service provider) and those who are allowed to on-sell its products. In line with this agreement there are normally some prerequisites that the partner must meet to become a preferred partner. These prerequisites may include things like:
- Training and certification
- Minimum sales volume and/or value
Being a preferred partner provides pre-determined discounts, advantages and privileges from the vendor to the partner.[1][2]
References
- ^ Gassmann, Oliver; Reepmeyer, Gerrit; Zedtwitz, Maximilian von (2008-02-19). Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry. Springer Science & Business Media. ISBN 978-3-540-77636-9.
- ^ Investment Management Regulation: ALI-ABA Course of Study Materials. American Law Institute-American Bar Association Committee on Continuing Professional Education. 2006.
 | This business term article is a stub. You can help Wikipedia by expanding it. |